Main menu


You are here

Mutations

RSV vaccine: Moderna, Pfizer’s race to obtain FDA approval process

Moderna, Pfizer’s new race: The RSV vaccine FDA approval process

...

Pfizer’s vaccine is already in the FDA approval process and Moderna CEO Stéphane Bancel told CNBC from Davos on Wednesday that it will be filing for FDA approval for its vaccine soon — it even had a plan in place for top executives to be ready to submit over the holidays if needed.

ALSO SEE: Moderna says its RNA vaccine was nearly 84% effective in preventing symptoms in adults 60 and older

 

...

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Covid-19 antibody levels jump among elderly after autumn booster--British study

...

Some 96.3% of people aged 80 and over in England were likely to have antibodies at the start of December 2022, up from 89.2% in early September.

For 75 to 79-year-olds, the proportion stands at 95.8%, up from 87.4%.   ...

The figures are “likely a result of the vaccination booster campaign”, according to the Office for National Statistics (ONS), which has published the data.

...

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Mutations
howdy folks